Promoterless cassettes for expression of alphavirus structural proteins

Details for Australian Patent Application No. 2008266807 (hide)

Owner Alphavax, Inc.

Inventors Kamrud, Kurt I.; Smith, Jonathan F.; Maughan, Maureen

Agent FB Rice

Pub. Number AU-B-2008266807

PCT Pub. Number WO2008/156829

Priority 60/936,637 21.06.07 US

Filing date 20 June 2008

Wipo publication date 24 December 2008

Acceptance publication date 16 August 2012

International Classifications

C07H 21/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 38/00 Medicinal preparations containing peptides

A61K 39/12 Medicinal preparations containing antigens or antibodies - Viral antigens

C07K 14/705 Peptides having more than 20 amino acids

C12N 15/40 Mutation or genetic engineering - Proteins from RNA viruses, e.g. flaviviruses

C12N 15/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2008/156829 Priority application(s): WO2008/156829

16 August 2012 Application Accepted

  Published as AU-B-2008266807

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008266813-Process and apparatus for adsorptive bubble separation using a dense foam

2008266798-Short acting phenylalkylamine calcium channel blockers and uses thereof